News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Videos|December 29, 2022

Importance of Screening for T1D

Author(s)Tina Q Tan, MD, FAAP, FIDSA, FPIDS, Kimberly Simmons, MD

Tina Q Tan, MD, and Kimberly Simmons, MD, comment on early screening for pediatric T1D, screening options, and next steps once a child has tested positive for 2 or more autoantibodies.

Episodes in this series

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 1 Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

EP. 2 Stages and Progression of T1D

EP. 2 Stages and Progression of T1D

EP. 3 Importance of Screening for T1D

EP. 3 Importance of Screening for T1D

EP. 4 Lifestyle Management in T1D

EP. 4 Lifestyle Management in T1D

EP. 5 Approaching T1D Screening Retesting

EP. 5 Approaching T1D Screening Retesting

EP. 6 Emerging Treatments in T1D

EP. 6 Emerging Treatments in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 7 Blood Glucose Monitoring in T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

EP. 8 Key Takeaways for Screening and Diagnosis of T1D

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Artificial sweeteners show mixed effects on diabetes management | Image Credit: © Proxima Studio - stock.adobe.com.

Artificial sweeteners show mixed effects on diabetes management

ByMorgan Ebert, Managing Editor

November 2nd 2025

Novel therapies for type 1 diabetes | Image Credit: © martenaba - stock.adobe.com.

Novel therapies for type 1 diabetes

ByMichelle Nieland, PharmD ,Carlton Lee, PharmD, MPH, FASHP, FPPAG, BCPPS

November 1st 2025

FDA accepts Afrezza sBLA for pediatric diabetes | Image credit: Contemporary Pediatrics

FDA accepts Afrezza sBLA for pediatric diabetes

ByMorgan Ebert, Managing Editor,Joshua Fitch, Senior Editor

October 13th 2025

What to expect from the 2025 AAP National Conference & Exhibition | Image Credit: © KOTO - stock.adobe.com.

What to expect from the 2025 American Academy of Pediatrics National Conference & Exhibition

ByJoshua Fitch, Senior Editor

September 23rd 2025

Tirzepatide effective in reducing A1c in children, adolescents with type 2 diabetes | Image Credit: © Fauzi - © Fauzi - stock.adobe.com.

Tirzepatide effective in reducing A1c in children, adolescents with type 2 diabetes

ByJoshua Fitch, Senior Editor

September 19th 2025

Latest CME

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice

Paul G. Auwaerter, MD, MBA; Paul P. Doghramji, MD, FAAFP; Aruna Subramanian, MD

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Clinical Consultations™: Addressing Elevated Phosphate Levels in Patients with END-STAGE Kidney Disease (ESKD)

Anil K. Agarwal, MD, FACP, FASN, FNKF, FASDIN; Jay B. Wish, MD

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Advances In: Managing Hyperphosphatemia in Chronic Kidney Disease – Bridging Treatment Gaps With Novel Therapies

Glenn M. Chertow, MD, MPH; Anjay Rastogi, MD, PhD

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Case-based Simulation

SimulatED™: Understanding the Role of Genetic Testing in Patient Selection for Anti-Amyloid Therapy

Nicholas Doher, DO; Babak Tousi, MD

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Burst CME™: Addressing Inadequate Response to Anti-TNF Therapy in Patients With Rheumatoid Arthritis

Jeffrey A. Sparks, MD, MMSc

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Community Practice Connections™: Cases and Conversations – Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis

Frank B. Cortazar, MD; Lindsay S. Lally, MD

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Health system–based clinical pathway improves pediatric lipid screening rates

FDA approves linaclotide (Linzess) for pediatric patients aged 7 years and older with IBS-C

Wesley Kufel, PharmD, discusses doxycycline for post-exposure prevention of Lyme disease in young children

Linaclotide demonstrates positive long-term safety

Silvana Bonilla, MD, discusses geographic patterns of H. Pylori in pediatric digestive disease

© 2025 MJH Life Sciences^®

All rights reserved.